TP73 and non-small cell lung carcinoma: Furthermore, TP73‐AS1 augmented the migration and invasion abilities of NSCLC cells by depressing the expression levels of E‐cadherin, JanD, and HLJ1 while enhancing MMP2 and MMP9 expression.